Skip to main content

Table 1 Demographic characteristics of AA-DHS participants, by presence/absence of CAC

From: Genome-wide association study of coronary artery calcified atherosclerotic plaque in African Americans with type 2 diabetes

Variables

CAC 130 HU <10 (N = 346)

CAC 130 HU ≥10 (N = 345)

ALL (N = 691)

P-value

Mean

SD

Median

Mean

SD

Median

Mean

SD

Median

Age (years)

52.8

8.7

52.0

59.8

9.0

60.0

56.3

9.6

56.0

<0.0001

Female (%)

66.5

53.6

60.1

0.0006

African Ancestry proportion (%)

76.4

14.9

78.9

73.8

16.0

76.4

75.1

15.5

78.0

0.05

Diabetes duration (years)

8.4

6.1

7.0

12.2

9.3

10.0

10.3

8.1

8.0

<0.0001

HbA1c (%)

8.3

2.3

7.8

8.1

1.9

7.6

8.2

2.1

7.7

0.94

C-reactive protein (mg/dl)

1.0

1.5

0.5

0.9

1.3

0.4

0.9

1.4

0.5

0.27

Glucose (mg/dl)

154.7

68.8

138.0

148.9

67.1

132.0

151.7

68.0

136.0

0.19

Low density lipoprotein cholesterol (mg/dl)

108.5

37.4

106.0

107.1

36.6

103.0

107.8

36.9

105.0

0.46

High density lipoprotein cholesterol (mg/dl)

48.2

14.4

46.0

47.8

14.4

45.0

48.0

14.4

46.0

0.51

Triglycerides (mg/dl)

128.2

112.0

104.0

128.2

130.4

100.0

128.2

121.5

102.0

0.66

Body Mass Index (kg/m2)

35.9

8.6

34.6

34.4

8.2

32.9

35.1

8.4

33.7

0.02

CAC 90 (Hounsfield unit)

8.8

16.1

1.5

1212.0

1810.9

442.0

609.4

1413.3

44.0

NA

CAC 130 (Hounsfield unit)

0.8

1.8

0.0

445.1

646.1

190.5

222.6

507.5

9.5

NA

ACE inhibitor use (%)

46.8

51.3

49.1

0.25

Current smoker (%)

20.3

25.2

22.8

0.007

Past smoker (%)

31.7

40.2

36.0

0.001

Hypertension (%)

78.0

89.1

83.6

0.0001

Lipid-lowering medication (%)

39.5

53.4

46.4

0.0004